| Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial M Valgimigli, A Gagnor, P Calabró, E Frigoli, S Leonardi, T Zaro, ... The Lancet 385 (9986), 2465-2476, 2015 | 1464 | 2015 |
| Use of the instantaneous wave-free ratio or fractional flow reserve in PCI JE Davies, S Sen, HM Dehbi, R Al-Lamee, R Petraco, SS Nijjer, R Bhindi, ... New England Journal of Medicine 376 (19), 1824-1834, 2017 | 1000 | 2017 |
| Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial M Sabate, A Cequier, A Iñiguez, A Serra, R Hernandez-Antolin, V Mainar, ... The Lancet 380 (9852), 1482-1490, 2012 | 544 | 2012 |
| Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial O Varenne, S Cook, G Sideris, S Kedev, T Cuisset, D Carrié, T Hovasse, ... The Lancet 391 (10115), 41-50, 2018 | 404 | 2018 |
| Long-Term (>10 Years) Clinical Outcomes of First-in-Human Biodegradable Poly-l-Lactic Acid Coronary Stents: Igaki-Tamai Stents S Nishio, K Kosuga, K Igaki, M Okada, E Kyo, T Tsuji, E Takeuchi, ... Circulation 125 (19), 2343-2353, 2012 | 330 | 2012 |
| Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a … M Valgimigli, E Frigoli, S Leonardi, P Vranckx, M Rothenbühler, M Tebaldi, ... The Lancet 392 (10150), 835-848, 2018 | 293 | 2018 |
| Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the … M Sabaté, S Windecker, A Iñiguez, L Okkels-Jensen, A Cequier, ... European heart journal 37 (3), 229-240, 2016 | 282 | 2016 |
| Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double … M Valgimigli, G Campo, N de Cesare, E Meliga, P Vranckx, A Furgieri, ... Circulation 119 (25), 3215-3222, 2009 | 275* | 2009 |
| Unusual CD4+CD28nullT Lymphocytes and Recurrence of Acute Coronary Events G Liuzzo, LM Biasucci, G Trotta, S Brugaletta, M Pinnelli, G Digianuario, ... Journal of the American College of Cardiology 50 (15), 1450-1458, 2007 | 275 | 2007 |
| Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a … M Sabaté, S Brugaletta, A Cequier, A Iñiguez, A Serra, ... The Lancet 387 (10016), 357-366, 2016 | 248 | 2016 |
| Very late scaffold thrombosis: intracoronary imaging and histopathological and spectroscopic findings L Räber, S Brugaletta, K Yamaji, CJ O’Sullivan, S Otsuki, T Koppara, ... Journal of the American College of Cardiology 66 (17), 1901-1914, 2015 | 226 | 2015 |
| Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective C Tamburino, A Latib, RJ Van Geuns, M Sabate, J Mehilli, T Gori, ... EuroIntervention 11 (1), 45-52, 2015 | 187 | 2015 |
| Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching … S Brugaletta, T Gori, AF Low, P Tousek, E Pinar, J Gomez-Lara, ... JACC: Cardiovascular Interventions 8 (1 Part B), 189-197, 2015 | 175 | 2015 |
| Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time … S Brugaletta, JH Heo, HM Garcia-Garcia, V Farooq, RJ van Geuns, ... European heart journal 33 (11), 1325-1333, 2012 | 174 | 2012 |
| Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (tailoring treatment with tirofiban … G Campo, L Fileti, N de Cesare, E Meliga, A Furgieri, F Russo, ... Journal of the American College of Cardiology 56 (18), 1447-1455, 2010 | 169 | 2010 |
| Acute kidney injury after radial or femoral access for invasive acute coronary syndrome management: AKI-MATRIX G Andò, B Cortese, F Russo, M Rothenbühler, E Frigoli, G Gargiulo, ... Journal of the American College of Cardiology 69 (21), 2592-2603, 2017 | 156 | 2017 |
| Prognostic value of QFR measured immediately after successful stent implantation: the international multicenter prospective HAWKEYE study S Biscaglia, M Tebaldi, S Brugaletta, E Cerrato, A Erriquez, G Passarini, ... JACC: Cardiovascular Interventions 12 (20), 2079-2088, 2019 | 145 | 2019 |
| Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? S Brugaletta, MD Radu, HM Garcia-Garcia, JH Heo, V Farooq, C Girasis, ... Atherosclerosis 221 (1), 106-112, 2012 | 144 | 2012 |
| Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events … L Ortega-Paz, D Capodanno, T Gori, H Nef, A Latib, G Caramanno, ... EuroIntervention 12 (17), 2110-2117, 2017 | 143 | 2017 |
| Background, incidence, and predictors of antiplatelet therapy discontinuation during the first year after drug-eluting stent implantation I Ferreira-González, JR Marsal, A Ribera, G Permanyer-Miralda, ... Circulation 122 (10), 1017-1025, 2010 | 142 | 2010 |
Luigi M Biasucciuniversita' cattolica romaAdresse e-mail validée de virgilio.it
